Quantcast

Latest Servier Stories

2014-08-27 08:28:22

THOUSAND OAKS, Calif., Aug. 27, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). Ivabradine is an oral drug that inhibits the I(f) current ("funny" current) in the sinoatrial node, the body's cardiac pacemaker.(1) Ivabradine works to slow the heart rate without negative effects on myocardial contractility or ventricular...

2014-04-14 12:31:23

Considerable Opportunity Exists for Therapies Offering Reductions in Mortality and Hospitalization Rates, According to Findings from Decision Resources Group BURLINGTON, Mass., April 14, 2014 /PRNewswire/ -- Decision Resources Group finds that Servier's ivabradine (procoralan) is set to become the clinical gold-standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's sound clinical...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related